Cargando…

Potassium-competitive acid blockers and gastroesophageal reflux disease

Proton pump inhibitors (PPIs), the most commonly used antisecretory medi-cations in the management of reflux illness, virtually eliminate elective surgery for ulcer disease, and relegate anti-reflux surgery to patients with gastroesophageal reflux disease (GERD) who are inadequately managed by medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leowattana, Wattana, Leowattana, Tawithep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372813/ https://www.ncbi.nlm.nih.gov/pubmed/36161043 http://dx.doi.org/10.3748/wjg.v28.i28.3608

Ejemplares similares

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

COVID-19 vaccination and cardiac dysfunction
por: Leowattana, Wattana, et al.
Publicado: (2022)

Dengue hemorrhagic fever and the liver
por: Leowattana, Wattana, et al.
Publicado: (2021)

Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation
por: Leowattana, Wattana, et al.
Publicado: (2022)

Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022)

Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatments for resectable carcinoma of the esophagus
por: Leowattana, Wattana, et al.
Publicado: (2023)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
por: Leowattana, Wattana
Publicado: (2021)

Tuberculosis of the spine
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatment for advanced pancreatic cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
por: Masaoka, Tatsuhiro, et al.
Publicado: (2018)

Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
por: Rawla, Prashanth, et al.
Publicado: (2018)

Endoscopic anti-reflux therapy for gastroesophageal reflux disease
por: Rodríguez de Santiago, Enrique, et al.
Publicado: (2021)

Focus on gastroesophageal reflux disease in patients with cystic fibrosis
por: Bongiovanni, Annarita, et al.
Publicado: (2020)

Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date
por: Sugano, Kentaro
Publicado: (2018)

Risk factors for gastroesophageal reflux disease and analysis of genetic contributors
por: Argyrou, Alexandra, et al.
Publicado: (2018)

Proposed approach to the challenging management of progressive gastroesophageal reflux disease
por: Labenz, Joachim, et al.
Publicado: (2018)

Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making
por: Klenzak, Scott, et al.
Publicado: (2018)

Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia
por: Asaoka, Daisuke, et al.
Publicado: (2017)

Nucleos(t)ide analogues treatment outcome in genotype B and C chronic hepatitis B
por: Aung, Myo Nyein, et al.
Publicado: (2010)

Treatment strategies for reflux esophagitis including a potassium‐competitive acid blocker: A cost‐effectiveness analysis in Japan
por: Habu, Yasuki, et al.
Publicado: (2021)

Acid inhibition and gastroesophageal reflux disease.
por: Sachs, G.
Publicado: (1999)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

Protonated Form: The Potent Form of Potassium-Competitive Acid Blockers
por: Luo, Hua-Jun, et al.
Publicado: (2014)

The Effect of Food on the Pharmacokinetics of the Potassium‐Competitive Acid Blocker Vonoprazan
por: Mulford, Darcy J., et al.
Publicado: (2021)

Gastroesophageal Reflux Disease
por: Kulkarni, Gaurav V., et al.
Publicado: (2013)

INFLUENCE OF EXERCISE TESTING IN GASTROESOPHAGEAL REFLUX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
por: MENDES-FILHO, Antonio Moreira, et al.
Publicado: (2014)

Gastric polyps' regression after potassium‐competitive acid blocker cessation
por: Iwamuro, Masaya, et al.
Publicado: (2022)

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
por: Kim, Tae Ho
Publicado: (2023)

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases
por: Oshima, Tadayuki, et al.
Publicado: (2018)

Validation of the Korean Version of the Gastroesophageal Reflux Disease Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease
por: Gong, Eun Jeong, et al.
Publicado: (2019)

Gastro-oesophageal reflux disease and eosinophilic oesophagitis: What is the relationship?
por: Wong, Stephanie, et al.
Publicado: (2018)

Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
por: Maeda, Osamu, et al.
Publicado: (2019)

Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride
por: Kraemer, Yannick, et al.
Publicado: (2022)

Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
por: Mori, Hideki, et al.
Publicado: (2019)

Nighttime Acid Reflux in Gastroesophageal Reflux Disease - Is It a Problem That Can Be Solved?
por: Choi, Yonghoon, et al.
Publicado: (2023)

Silent Gastroesophageal Reflux Disease
por: Lu, Ching-Liang
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1i3c6atimhc0no8o2hq1pnj0s9